Factors affecting the implementation of guideline-based prophylactic antiemetic therapy for chemotherapy-induced nausea and vomiting in Japan: a protocol for a hospital-based qualitative study

• Yosuke Uchitomi,
• Junko Saito,
• Maiko Fujimori,
• Taichi Shimazu,
• Ayako Okuyama,
• Sadamoto Zenda,
• Ayumu Matsuoka,
• Akiko Yaguchi-Saito,
• Yuki Kaji,
• Miyuki Odawara,
• Aki Otsuki

Affiliations

Yosuke Uchitomi

Innovation Center for Supportive, Palliative and Psychosocial Care, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan

Junko Saito

Behavioral Science Division, Center for Public Health Sciences, National Cancer Center Japan, Chuo-ku, Tokyo, Japan

Maiko Fujimori

Division of Behavioral Sciences, National Cancer Center Institute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji,Chuo-ku, Tokyo, 104-0045, Japan

Taichi Shimazu

7 Division of Prevention, Center for Public Health Sciences, National Cancer Center Japan, Tokyo, Chuo-ku, Japan

Ayako Okuyama

1 Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan

Sadamoto Zenda

Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan

Ayumu Matsuoka

Department of Reproductive Medicine, Chiba University Graduate School of Medicine School of Medicine, Chiba, Japan

Akiko Yaguchi-Saito

Division of Behavioral Sciences, National Cancer Center Institute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji,Chuo-ku, Tokyo, 104-0045, Japan

Yuki Kaji

Division of Behavioral Sciences, National Cancer Center Institute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji,Chuo-ku, Tokyo, 104-0045, Japan

Miyuki Odawara

Division of Behavioral Sciences, National Cancer Center Institute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji,Chuo-ku, Tokyo, 104-0045, Japan

Aki Otsuki

Division of Behavioral Sciences, National Cancer Center Institute for Cancer Control, National Cancer Center, 5-1-1 Tsukiji,Chuo-ku, Tokyo, 104-0045, Japan